See also this year's filing and all EDGAR filings for this company.
PDF Report 0001822462_2025_Foghorn_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001822462, Foghorn Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 249,601,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 34,381,000 |
| 4 | LiabilitiesCurrent | 66,989,000 |
| 5 | LiabilitiesNoncurrent | 262,521,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,860,845 |
| 9 | ResearchAndDevelopmentExpense | 83,417,572 |
| 10 | remainder_Expenses | 2,958,321 |
| 11 | remainder_Revenues | 19,638,905 |
| 12 | remainder_NetIncome | 18,700,819 |
| 13 | remainder_ComprehensiveNetIncome | 1,945,635 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 283,982,000 |
| 1 | Liabilities | 329,510,000 |
| 2 | Expenses | 107,236,738 |
| 3 | Revenues | 19,638,905 |
| 4 | StockholdersEquity | -45,528,000 |
| 5 | NetIncome | -68,897,014 |
| 6 | ComprehensiveNetIncome | -67,924,196 |
| 7 | BaseVar | 380,507,048 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.545 |
| 9 | EconomicCapitalRatio | 1.38 |